functions as an inhibitory receptor by signaling through two inhibitory ITIM motifs (V/IxYxxL/V), whereas NKG2C/CD94 functions as an activating receptor by associating with the DAP12 signaling adapter (Lanier, 1998) . How NK cells integrate multiple opposing signals into a single output (kill or tolerate) is not well understood, although it is generally thought that inhibitory signals predominate. Perhaps enabling this dominance, NKG2A/CD94 binds to HLA-E complexes with affinities consistently six-fold stronger than NKG2C/CD94 (4) . This trend has also seen in other NK receptor families with paired stimulatory/inhibitory receptors, including the KIR and Ly49 families. It has been proposed that some activating receptors may have evolved to bind pathogen-derived ligands directly, but only one example has been firmly established: the recognition of mCMV m157 by murine Ly49H (5, 6) .
HLA-E is highly homologous to classical MHC proteins but has acquired critical changes that restrict the repertoire of peptides it binds to nonamers derived from the leader sequences of classical MHC (3, (7) (8) (9) (10) . The HLA allele from which the nonamer peptide is derived significantly influences the strength of interaction with the NKG2x/CD94 receptor, despite single, [ 4 ] conserved substitutions in most cases (3, 4, 8, 11, 12) . The importance of HLA-E in viral surveillance is underscored by the fact that it is targeted for subversion by the CMV protein gpUL40, which contains the HLA-E peptide sequence VMAPRTLIL within its leader sequence (13, 14) .
Previous studies have not conclusively determined how NKG2x/CD94 receptors recognize different HLA-E-restricted peptide, but binding studies have shown that the two most critical peptide contact points for huNKG2x/CD94 are positions P5, an invariant Arg, and P8, a variable hydrophobic residue in class I leaders (12, 15, 16) . Based on the structure of MICA bound to NKG2D, Li and coworkers proposed that NKG2A/CD94 would bind HLA-E with CD94 oriented over the α1 helix of HLA-E and C-terminal part of the peptide, and NKG2A over the α2 helix (17). Subsequent binding and mutagenesis studies of HLA-E helices (4, 12, 18) provided further support for this orientation, indicating CD94 is likely responsible for reading out the C-terminus of the peptide. The structural basis for affinity differences between NKG2x/CD94 receptors has also not been conclusively determined, partly because of the high sequence similarity between these receptors. Here we present the crystal structure of a complex between NKG2A/CD94 and HLA-E that directly answers these questions and suggests an alternate role for the activating NKG2C/CD94 receptor.
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Results
Soluble forms of the ectodomains of NKG2A/CD94 and HLA-E were refolded in vitro from bacterial inclusion bodies (4) . For crystallization, HLA-E was complexed with the nonamer peptide derived from HLA-G (VMAPRTLFL), which binds NKG2x/CD94 with the highest affinity of any HLA-E/peptide combination so far tested (4) . Initial phases were determined by molecular replacement using previously-determined structures of CD94 (19) and HLA-E (10) as search models (Supplementary table 1 Figure 1D ). The validity of our modeling, beyond reasonable refinement statistics (Supplementary table 1) , is demonstrated by consistency with previous binding and modeling studies (4, 12, 17, 18) and good agreement between NKG2A/CD94 from our structure and its recently determined crystal structure (PDB accession 3BDW, (12) ). The de-novo built NKG2A molecules from our structure superimpose with an rmsd of 0.59-0.60 Å with the NKG2A molecules from 3BDW. In addition, the NKG2A/CD94 receptor structure and our complex structure superimpose with rmsd's of 0.76 to 0.86 Å ( Figure 1C ), resulting in essentially identical pseudo-dyad axes relating NKG2A to CD94 (~175°) free or bound to HLA-E. For our final structure, we replaced the de novo-built NKG2A moiety with its actual crystal structure primarily to improve the stereochemistry, since the difference in refinement statistics using the de novo model or 3BDW was modest. Despite application of non-crystallographic symmetry (NCS) restraints throughout refinement, the orientation of the two NKG2A/CD94 receptors on their respective HLA-E ligands differs significantly by ~5°, indicating some flexibility in binding. We also note that the overall orientation of receptor on ligand, ~67° (Fig 1B) , is more orthogonal than predicted by previous modeling attempts, at ~40° (12) . [ 6 ] In the receptor, two elements are primarily responsible for the formation of the interface between NKG2A and CD94 ( Figure 2 ). One is formed on the membrane-proximal (N-terminal) face of the heterodimer where β-strand 1 (β1) from both NKG2A and CD94 bridge the dimer interface and join β-sheet 1 (β1, β2 and β7) of each monomer into an extended β-sheet containing a total of six β-strands.. The second region of the heterodimer interface is formed by CD94 residues 107-111 (sequence: MFSSS) and NKG2A residues 168-171 (sequence: IISP), which are just C-terminal to the 2 nd α-helix of NKG2A.
In the complex, CD94 binds over the α1 helix of HLA-E and unambiguously contributes all contacts to the C-terminal portion of the peptide, while NKG2A sits over the over the α2 helix ( Figure 3A ). Sullivan and coworkers reported that a CD94 N158A mutation actually increased binding to HLA-E ~three-fold, supporting a direct, main-chain interaction between CD94 N158 and P8
Phe .
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Mapping receptor/ligand interface contacts in our structure is largely consistent with previous mutagenesis studies (12, 18) , predicting that all residues that, when mutated, decrease affinity by ten-fold or more are also direct contacts (HLA-E  Q72 , HLA-E  R75 , HLA-E  V76 , HLA-E  E152 , HLA-E  D162 , CD94  Q112 , CD94   Q114 , CD94 N160 , CD94 162 , CD94 D163 , CD94 E164 ; Figure 3C ).
Residues where more modest three-to four-fold affinity decreases are seen when mutated
, HLA-E R65 , HLA-E R75 , HLA-E E166 ; CD94 D168 ) do not appear to be direct contacts in our analysis. Several contacts in the complex structure (HLA-E H155 , HLA-E D69 , NKG2A S172 ) only demonstrated a modest (~two-fold) decrease in affinity when mutated, suggesting that these residues do not contribute significantly to ∆G of binding.
Individuals with the correct HLA haplotype can generate TCRs that specifically recognize HLA-E complexes presenting hCMV UL40-derived peptides (VMAPRTLIL, (20)).
Comparison of our structure with the complex crystal structure of one such TCR, KK50.4, bound to HLA-E demonstrates that the KK50.4 and NKG2A/CD94 footprints on HLA-E are essentially overlapping surfaces ( Figure 3D , (21)). CD94 Q112 and KK50.4 residues βR98 and αΝ97 contact the peptide in comparable ways, intercalating between the side-chains of P5 Arg and P8 Phe and contacting the main-chain of P6 Thr ( Figure 3B ). NKG2A/CD94 buries more surface area than KK50.4 (~2600 Å 2 versus ~2150 Å 2 ), and consistent with this, the affinity of NKG2A/CD94 for HLA-E is considerably higher (~1 µM vs 30 µM).
Why does NKG2A/CD94 bind any given HLA-E/peptide complex with a ~six-fold higher affinity than NKG2C/CD94, given their high sequence identity (95%), different at only six positions ( Figure 2) ? Three of these differences are in a loop (NKG2A residues 167-170) that forms a significant part of the interface with CD94 ( Figure 2 ). Residues of both NKG2A and CD94 adjacent to this interface make significant contacts with HLA-E/peptide: CD94 residues 112-114 interact with both the peptide and α1 helix of HLA-E, and NKG2A residues P171 and S172 likely contact HLA-E H155 and the peptide at P5 Arg . In order to test whether residues 167-170 Comparable results have also been reported by a recent study (12) .
Because the NKG2x residues that account for the affinity difference form the interface with CD94 and do not appear to directly contact HLA-E/peptide, the affinity difference is likely due to adjustments in heterodimer orientation that indirectly alters interactions with HLA-E.
Residues adjacent to the NKG2A-CD94 interface include NKG2A P171 and CD94 Q112 , both of which potentially contact peptide P5 Arg . This raised the possibility that the P5 Arg also contributes to the affinity difference between NKG2A and NKG2C. In order to test this, we generated HLA-E presenting the HLA-G nonamer with P5 mutated to Lys (VMAPKTLFL) and measured the binding affinity to NKG2A/CD94 and NKG2C/CD94. The affinities for both receptors were very similar (10 µM for NKG2A/CD94 and 12 µM for NKG2C/CD94, respectively. All codons listed had a posterior probability >95% in NSsites. These results are particularly intriguing because NKG2A I168 , NKG2A P171 and NKG2C S166 lie at the interface with CD94 and are critical to determining the overall affinity of the interaction with HLA-E. NKG2C
codon 195, on the other hand, is distant from the HLA-E interacting surface.
Because of the strong signals of positive selection in HLA-E interacting residues, we hypothesized that NKG2x/CD94 receptors may also be interacting with a pathogen-derived ligand. Potential candidates included two MHC-related CMV proteins, gpUL142 and gpUL18.
gpUL18, which like class I MHC associates with β 2 -microglobulin (β 2 m) and peptide, binds with very high affinity (K D in the low nM range) to the inhibitory NK receptor LIR1/ILT2/CD85j (24, 25) . Several recent studies, while circumstantial, have suggested the possibility of direct interactions between NKG2C/CD94 and CMV-encoded proteins, including gpUL18 (26, 27). In order to assess this possibility, surface plasmon resonance binding studies, in which glycosylated gpUL18 was chip-coupled, clearly demonstrate an interaction between NKG2C/CD94 and gpUL18, but not between NKG2A/CD94 and gpUL18 ( Figure 4B ). While we cannot satisfactorily fit these data with appropriate binding models (possibly due to heterogeneity in this [ 10 ] preparation of the heavily glycosylated gpUL18 protein), precluding quantitation, the interaction is likely to be weak, with a K D in the 10-100 µM range The use of the same gpUL18-coupled surface for both receptors provided an internal binding control. This result confirms the possibility that NKG2x/CD94 receptors are under positive selection due to genetic conflict with pathogen-associated proteins.
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Discussion
Low resolution structures can be a rich source of information, providing valuable insight into biological questions (28) . Despite the low resolution of this analysis, the NKG2A/CD94-HLA-E complex structure reveals important details about the recognition mechanism of this important family of immunoreceptors, accounting both for affinity differences between NKG2A and NKG2C for HLA-E and between different peptides for NKG2x receptors. Sequence differences in NKG2x residues 167-170, which form part of the heterodimer interface, account for the affinity difference between NKG2A/CD94 and NKG2C/CD94 for given HLA-E/peptide complexes. While a crystal structure of NKG2C/CD94
is not yet available for comparison, we hypothesize that these interface residues indirectly affect ligand affinity through changes in the overall arrangement of domains in NKG2x/CD94 receptors. In order for this mechanism to explain observed affinity differences, NKG2x/CD94 receptors should be relatively rigid, unlike NKG2D homodimers, which show significant interface flexibility (29, 30) . The near-perfect superimposibility of the ligand-bound and free states of NKG2A/CD94 supports such a conclusion. Studies of the murine C-type lectin-like Ly49 family of receptors, which function as homodimers in binding to MHC ligands, have also demonstrated that residues at the homodimer interface critically affect ligand binding (31) (32) (33) .
Our comparative analysis across primate species revealed that both NKG2A and NKG2C
are evolving under strong positive selection, consistent with involvement in a host-pathogen conflict. We note that this is not the only possible explanation of the data. However, residues encoded by codons with the highest signal for positive selection either lie in or near the HLA-E binding surface or in the NKG2x/CD94 interface (with the exception of NKG2C K195 ), positions that may affect ligand interactions directly or indirectly. In support of the host-pathogen conflict hypothesis, direct binding studies do show a specific, though weak, interaction between a likely extant candidate, hCMV gpUL18 and NKG2C/CD94, though not between NKG2A/CD94 and gpUL18. The nature of this interaction suggests that NKG2x/CD94 receptors may directly [ 12 ] interact with virally-encoded proteins, possibly hCMV gpUL18 or related proteins, either as part of a viral immunoevasion strategy, usurping the inhibitory receptor NKG2A/CD94 as gpUL18 appears to subvert LIR1, or as an immune system response to such an evasion strategy, by directly engaging the activating receptor NKG2C/CD94.
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Materials and Methods
Protein expression & purification: Human NKG2A (residues 99 to 233 plus an N-terminal 6xHis tag) and CD94 (residues 31-179) were both expressed and purified as previously described (4).
Mutations in NKG2A and NKG2C were introduced using the QuikChange procedure (Stratagene). For crystallography, NKG2A/CD94 was additionally digested overnight at room temperature with bromelain (Calbiochem) at a ratio of 30:1. The HLA-E complex, containing a nonamer peptide derived from the leader sequence of HLA-G (VMAPRTLFL), was refolded by dilution as previously described (10) and purified by size exclusion and ion exchange chromatography to separate complexes from free heavy chains. For the final step of purification, NKG2A/CD94 and HLA-E were co-purified by size exclusion chromatography.
Crystallography: NKG2A/CD94-HLA-E complex was concentrated to 4.0 mg/mL and crystallized by hanging drop vapor diffusion at 18°C by mixing equivalent volumes of protein X-ray data were collected at the Advanced Light Source (Berkeley, California), beamline 8.2.2, and were processed with DENZO/Scalepack; phases were determined by molecular replacement using AMoRe, as implemented in the CCP4 suite of programs (34), with HLA-E (1KPR.pdb) and a CD94 monomer (1B6E.pdb) as independent search models. Initial phases were improved using the density modification program DM (CCP4 suite). A homology model of NKG2A based on the structure of CD94 was placed into the electron density manually using COOT (35) and rebuilt according to the electron density. When submitted to the DALI server (36), this partially built NKG2A identified DC-SIGN (1SL6.pdb) as the closest structural homolog of NKG2A. DC-SIGN was then used as a reference molecule to complete the first NKG2A molecule. This first NKG2A/CD94 complex was docked onto the second HLA-E [ 14 ] molecule, creating our first model for the entire AU, encompassing two complete complexes. A TLS restrained refinement was performed, which improved R work to 0.34 and R free to 0.38. We completed our model with minimal manual building into regions where density was unequivocal.
Our completed refined structure showed an overall R value of 0.33 and R free of 0.37. Recently the structure of NKG2A/CD94 by itself was published (3BDW.pdb). We carried a further round of rigid body refinement using the NKG2A coordinates from this structure, with a final R value of 32.2 and R free of 35.5. NCS restraints were imposed throughout refinement.
Our initial solvent-flattened map, which was unbiased with respect to NKG2A, showed structural features not easily predicted from sequence analysis alone. We attempted to use CD94
and NKG2D, the two closest matches in terms of sequence identity, to generate our initial NKG2A model. However, based on a DALI search the electron density of NKG2A more closely resembled DC-SIGN, CD69 and tetranectin, all lectin or lectin-like proteins with lower sequence identity to NKG2A, most likely due to the 2 nd α-helix present in these molecules but not CD94. NKG2x/CD94 and HLA-E were carried out as described (4) . To assess the gpUL18-NKG2x/CD94 interaction, ~1000 response units gpUL18 (the kind gift of Pamela Bjorkman) was [ 15 ] amine coupled to a CM sensor chip as described (24) with codeml from the PAML 3.14 software package (22) . To detect the selective pressures shaping the evolution of each gene, the multiple alignments were fit to an NSsites model that allowed positive selection (M8) or disallowed positive selection (M7), assuming the F3X4 model of codon frequencies. Likelihood ratio tests were performed to determine whether allowing the codons to evolve under positive selection would give a significantly better fit for the data. To identify specific codons that have undergone recurrent positive selection, we used the NSsites model in codeml from the PAML 3.14 software (22) . To confirm the sites identified by the NSsites approach, we also used the random effects method (REL) from the web-based DataMonkey package, with the Bayes significance factor cutoff set at 50 (23) . shown below. Additionally, CD94 residues that bind HLA-E/peptide are indicated by green triangles; NKG2A residues that bind HLA-E/peptide by red triangles; CD94 residues contacting NKG2A by magenta rectangles; and CD94 residues contacting NKG2A by cyan rectangles.
Residues in the alignments shaded blue highlight sequence differences between NKG2A and NKG2C. Paired cysteine residues in NKG2A that form intrachain disulfide bonds are numbered above the alignments from one to three. [ 18 ]
